+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-10-17Number of Pages: 175

Antithrombin Market (Application - Therapeutics, Research, and Diagnostics; Source - Human, and Goat Milk; Dosage Form - Lyophilized and Liquid) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights

2. Assumptions and Research Methodology 
     2.1. Assumptions
     2.2. Acronyms Used
     2.3. Research Methodology

3. Executive Summary
     3.1. Global Antithrombin Market Snapshot

4. Market Overview
     4.1. Product Overview
     4.2. Global Antithrombin Market Size (US$ Mn) Forecast, 2015-2025 
     4.3. Key Industry Events 
     4.4. Market Opportunity Map
     4.5. Porter's Five Forces 
     4.6. Global Antithrombin Market Outlook

5. Market Dynamics
     5.1. Drivers and Restraints Snapshot Analysis
     5.2. Drivers
            5.2.1. Acceptance of Antithrombin Therapy
            5.2.2. Rising prevalence of Hereditary Antithrombin deficiency
            5.2.3. Adoption of ATIII in adult ECMO 
            5.2.4. New therapeutic Indication
            5.2.5. Technological Advancements
            5.2.6. Expansion of R&D pipeline of protein/peptide drugs
     5.3. Restraints
            5.3.1. Use of Substitute & conventional anticoagulants
            5.3.2. Pricing Pressure hampering the growth of the market
            5.3.3. Increasing complexity of therapeutic is a huge challenge for manufacturers
            5.3.4. Lack of regulatory standards
     5.4. Global Antithrombin Market Opportunities
            5.4.1. Small biotech firms collaborating with large pharmaceutical companies to explore further growth
            5.4.2. High potential market opportunity in emerging countries
     5.5. Global Antithrombin Market Trends 
            5.5.1. Discovering new Indications and exploring use of Antithrombin products 
            5.5.2. Upcoming new methods of preparation of Antithrombin products 
     5.6. Antithrombin Market Pipeline Analysis – Snapshot
     5.7. Antithrombin Market Key Product /Brand Analysis Globally: Snapshot 

6. Global Antithrombin Market Analysis, by Application
     6.1. Key Findings 
     6.2. Introduction
     6.3. Global Antithrombin Market Value Share Analysis, by Application, 2016 -2025
            6.3.1. Global Antithrombin Market Forecast, by Application
            6.3.2. Global Antithrombin Market Analysis, by Application
     6.4. Global Antithrombin Market Attractiveness Analysis, by Application, 2015-2025

7. Global Antithrombin Market Analysis, by Source
     7.1. Key Findings 
     7.2. Introduction
     7.3. Global Antithrombin Market Value Share Analysis, by Source, 2016 -2025
            7.3.1. Global Antithrombin Market Forecast, by Source
            7.3.2. Global Antithrombin Market Analysis, by Source
     7.4. Global Antithrombin Market Attractiveness Analysis, by Source, 2015-2025

8. Global Antithrombin Market Analysis, by Dosage Form
     8.1. Key Findings 
     8.2. Introduction
     8.3. Global Antithrombin Market Value Share Analysis, by Dosage form, 2016 -2025
            8.3.1. Global Antithrombin Market Forecast, by Dosage form
            8.3.2. Global Antithrombin Market Analysis, by Dosage form
     8.4. Global Antithrombin Market Attractiveness Analysis, by Dosage form, 2015-2025

9. Global Antithrombin Market Analysis, by Region
     9.1. Global Market Scenario by Country
     9.2. Global Antithrombin Market Value Share Analysis, by Region, 2016 and 2025
            9.2.1. Global Antithrombin Market Forecast, by Region
     9.3. Global Antithrombin Market Attractiveness Analysis, by Region, 2015-2025

10. North America Antithrombin Market Analysis
     10.1. Key Findings
     10.2. Market Overview
     10.3. North America Antithrombin Market Value Share Analysis, by Country
     10.4. North America Antithrombin Market Forecast, by Country
     10.5. North America Antithrombin Market Value Share Analysis, by Application
     10.6. North America Antithrombin Market Forecast, by Application
     10.7. North America Antithrombin Market Value Share Analysis, by Source
     10.8. North America Antithrombin Market Forecast, by Source
     10.9. North America Antithrombin Market Value Share Analysis, Dosage Form
     10.10. North America Antithrombin Market Forecast, Dosage Form
     10.11. North America Antithrombin Market Attractiveness Analysis 

11. Europe Antithrombin Market Analysis
     11.1. Key Findings
     11.2. Market Overview
     11.3. Europe Antithrombin Market Value Share Analysis, by Country
     11.4. Europe Antithrombin Market Forecast, by Country
     11.5. Europe Antithrombin Market Value Share Analysis, by Application
     11.6. Europe Antithrombin Market Forecast, by Application
     11.7. Europe Antithrombin Market Value Share Analysis, by Source
     11.8. Europe Antithrombin Market Forecast, by Source
     11.9. Europe Antithrombin Market Value Share Analysis, Dosage Form
     11.10. Europe Antithrombin Market Forecast, Dosage Form
     11.11. Europe Antithrombin Market Attractiveness Analysis 

12. Asia Pacific Antithrombin Market Analysis
     12.1. Key Findings
     12.2. Market Overview
     12.3. Asia Pacific Antithrombin Market Value Share Analysis, by Country
     12.4. Asia Pacific Antithrombin Market Forecast, by Country
     12.5. Asia Pacific Antithrombin Market Value Share Analysis, by Application
     12.6. Asia Pacific Antithrombin Market Forecast, by Application
     12.7. Asia Pacific Antithrombin Market Value Share Analysis, by Source
     12.8. Asia Pacific Antithrombin Market Forecast, by Source
     12.9. Asia Pacific Antithrombin Market Value Share Analysis, Dosage Form
     12.10. Asia Pacific Antithrombin Market Forecast, Dosage Form
     12.11. Asia Pacific Antithrombin Market Attractiveness Analysis 

13. LATAM Antithrombin Market Analysis
     13.1. Key Findings
     13.2. Market Overview
     13.3. LATAM Antithrombin Market Value Share Analysis, by Country
     13.4. LATAM Antithrombin Market Forecast, by Country
     13.5. LATAM Antithrombin Market Value Share Analysis, by Application
     13.6. LATAM Antithrombin Market Forecast, by Application
     13.7. LATAM Antithrombin Market Value Share Analysis, by Source
     13.8. LATAM Antithrombin Market Forecast, by Source
     13.9. LATAM Antithrombin Market Value Share Analysis, Dosage Form
     13.10. LATAM Antithrombin Market Forecast, Dosage Form
     13.11. LATAM Antithrombin Market Attractiveness Analysis 

14. Rest of World Antithrombin Market Analysis
     14.1. Key Findings
     14.2. Market Overview
     14.3. Rest of World Antithrombin Market Value Share Analysis, by Country
     14.4. Rest of World Antithrombin Market Forecast, by Country
     14.5. Rest of World Antithrombin Market Value Share Analysis, by Application
     14.6. Rest of World Antithrombin Market Forecast, by Application
     14.7. Rest of World Antithrombin Market Value Share Analysis, by Source
     14.8. Rest of World Antithrombin Market Forecast, by Source
     14.9. Rest of World Antithrombin Market Value Share Analysis, Dosage Form
     14.10. Rest of World Antithrombin Market Forecast, Dosage Form
     14.11. Rest of World Antithrombin Market Attractiveness Analysis 

15. Competition Landscape
     15.1. Competition Matrix 
     15.2. Antithrombin Market: Heat Map Analysis By Company (2016)
     15.3. Company Profiles
            15.3.1. rEVO Biologics, Inc. 
                      15.3.1.1. Company Details
                      15.3.1.2. Business Overview
                      15.3.1.3. Financial Overview
                      15.3.1.4. Strategic Overview
                      15.3.1.5. SWOT Analysis
            15.3.2. Grifols 
                      15.3.2.1. Company Details
                      15.3.2.2. Business Overview
                      15.3.2.3. Financial Overview
                      15.3.2.4. Strategic Overview
                      15.3.2.5. SWOT Analysis
            15.3.3. Shire plc 
                      15.3.3.1. Company Details
                      15.3.3.2. Business Overview
                      15.3.3.3. Financial Overview
                      15.3.3.4. Strategic Overview
                      15.3.3.5. SWOT Analysis
            15.3.4. CSL Limited 
                      15.3.4.1. Company Details
                      15.3.4.2. Business Overview
                      15.3.4.3. Financial Overview
                      15.3.4.4. Strategic Overview
                      15.3.4.5. SWOT Analysis
            15.3.5. Kedrion S.p.A. 
                      15.3.5.1. Company Details
                      15.3.5.2. Business Overview
                      15.3.5.3. Financial Overview
                      15.3.5.4. Strategic Overview
                      15.3.5.5. SWOT Analysis
            15.3.6. Octapharma AG 
                      15.3.6.1. Company Details
                      15.3.6.2. Business Overview
                      15.3.6.3. Financial Overview
                      15.3.6.4. Strategic Overview
                      15.3.6.5. SWOT Analysis
            15.3.7. Dem ilac, Inc. 
                      15.3.7.1. Company Details
                      15.3.7.2. Business Overview
                      15.3.7.3. Financial Overview
                      15.3.7.4. Strategic Overview
                      15.3.7.5. SWOT Analysis
            15.3.8. Lee Bisolutions, Inc. 
                      15.3.8.1. Company Details
                      15.3.8.2. Business Overview
                      15.3.8.3. Financial Overview
                      15.3.8.4. Strategic Overview
                      15.3.8.5. SWOT Analysis
            15.3.9. Diapharma Group, Inc. 
                      15.3.9.1. Company Details
                      15.3.9.2. Business Overview
                      15.3.9.3. Financial Overview
                      15.3.9.4. Strategic Overview
                      15.3.9.5. SWOT Analysis
            15.3.10. Scripps Laboratories, Inc. 
                      15.3.10.1. Company Details
                      15.3.10.2. Business Overview
                      15.3.10.3. Financial Overview
                      15.3.10.4. Strategic Overview
                      15.3.10.5. SWOT Analysis

     15.4. Other Prominent Companies

List of Figures

Figure 01: Global Antithrombin Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: Market Value Share, by Region (2016)
Figure 03: Market Value Share, by Application (2016)
Figure 04: Market Value Share, by Source (2016)
Figure 05: Market Value Share, by Dosage Form (2016)
Figure 06: Global Antithrombin Market Value Share Analysis, by Application, 2016 and 2025
Figure 07: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2015–2025
Figure 08: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Research, 2015–2025
Figure 09: Global Antithrombin Market Revenue (US$ Mn) and
Figure 10: Global Antithrombin Market Attractiveness Analysis, by Application, 2017–2025
Figure 11: Global Antithrombin Market Value Share Analysis, by Source, 2016 and 2025
Figure 12: Global Antithrombin Market Revenue (US$ Mn), by Human Source, 2015–2025
Figure 13: Global Antithrombin Market Revenue (US$ Mn), by Goat Milk Source, 2015–2025
Figure 14: Global Antithrombin Market Revenue (US$ Mn), by Others, 2015–2025
Figure 15: Global Antithrombin Market Attractiveness Analysis, by Source, 2015–2025
Figure 16: Global Antithrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 17: Global Antithrombin Market Revenue (US$ Mn), by Lyophilized Dosage Form, 2015–2025
Figure 18: Global Antithrombin Market Revenue (US$ Mn), by Liquid Dosage Form, 2015–2025
Figure 19: Global Antithrombin Market Attractiveness Analysis, by Dosage Form, 2015–2025
Figure 20: Global Antithrombin Market Value Share Analysis, by Region, 2016 and 2025
Figure 21: Global Antithrombin Market Attractiveness Analysis, by Region, 2015–2025 
Figure 22: North America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 23: North America Antithrombin Market Attractiveness Analysis, by Country, 2017–2025
Figure 24: North America Antithrombin Market Value Share Analysis, by Country, 2016 and 2025
Figure 25: North America Antithrombin Market Value Share Analysis, by Application, 2016 and 2025
Figure 26: North America Antithrombin Market Value Share Analysis, by Source, 2016 and 2025
Figure 27: North America Antithrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 28: North America Antithrombin Market Attractiveness Analysis, by Application,
Figure 29: North America Antithrombin Market Attractiveness Analysis, by Source, 2017–2025
Figure 30: North America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 31: Europe Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 32: Europe Antithrombin Market Attractiveness Analysis, by Country, 2017–2025
Figure 33: Europe Antithrombin Market Value Share Analysis, by Country, 2016 and 2025
Figure 34: Europe Antithrombin Market Value Share Analysis, by Application, 2016 and 2025
Figure 35: Europe Antithrombin Market Value Share Analysis, by Source, 2016 and 2025
Figure 36: Europe Antithrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 37: Europe Antithrombin Market Attractiveness Analysis, by Application,
Figure 38: Europe Antithrombin Market Attractiveness Analysis, by Source, 2017–2025
Figure 39: Europe Antithrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 40: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 41: Asia Pacific Antithrombin Market Attractiveness Analysis, by Country, 2017–2025
Figure 42: Asia Pacific Antithrombin Market Value Share Analysis, by Country, 2016 and 2025
Figure 43: Asia Pacific Antithrombin Market Value Share Analysis, by Application, 2016 and 2025
Figure 44: Asia Pacific Antithrombin Market Value Share Analysis, by Source, 2016 and 2025
Figure 45: Asia Pacific Antithrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 46: Asia Pacific Antithrombin Market Attractiveness Analysis, by Application, 2017–2025
Figure 47: Asia Pacific Antithrombin Market Attractiveness Analysis, by Source, 2017–2025
Figure 48: Asia Pacific Antithrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 49: Latin America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 50: Latin America Antithrombin Market Attractiveness Analysis, by Country, 2017–2025
Figure 51: Latin America Antithrombin Market Value Share Analysis, by Country, 2016 and 2025
Figure 52: Latin America Antithrombin Market Value Share Analysis, by Application, 2016 and 2025
Figure 53: Latin America Antithrombin Market Value Share Analysis, by Source, 2016 and 2025
Figure 54: Latin America Antithrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 55: Latin America Antithrombin Market Attractiveness Analysis, by Application,
Figure 56: Latin America Antithrombin Market Attractiveness Analysis, by Source, 2017–2025
Figure 57: Latin America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 58: Rest of the World Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 59: Rest of the World Antithrombin Market Value Share Analysis, by Application, 2016 and 2025
Figure 60: Rest of the World Antithrombin Market Value Share Analysis, by Source, 2016 and 2025
Figure 61: Rest of the World Antithrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 62: Rest of the World Antithrombin Market Attractiveness Analysis, by Application, 2017–2025
Figure 63: Rest of the World Antithrombin Market Attractiveness Analysis, by Source, 2017–2025
Figure 64: Rest of the World Antithrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 65: Heat Map Analysis by Company (2016)
Figure 66: Revenue for the LFB Group (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 67: Breakdown of Net Sales, by Business Segment, 2016
Figure 68: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 69: Breakdown of Net Sales, by Business Segment, 2016
Figure 70: Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
Figure 71: Breakdown of Net Sales, by Region, 2016
Figure 72: CSL Limited Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 73: Breakdown of Net Sales by Business segments, 2016
Figure 74: Company Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016

List of Tables

Table 01: Global Antithrombin Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 02: Global Antithrombin Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 03: Global Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 04: Global Antithrombin Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 06: North America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 07: North America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 08: North America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 09: Europe Antithrombin Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 10: Europe Antithrombin Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 11: Europe Antithrombin Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 12: Europe Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 13: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 15: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 16: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 17: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 19: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 20: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 21: Rest of the World Antithrombin Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 22: Rest of the World Antithrombin Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 23: Rest of the World Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025


 
 
Back To Top